phase 2 trial
![scancell, dna vaccine, skin cancer, melanoma, scib1, phase 2 trial, survival rate](https://pharmtales.com/wp-content/uploads/2023/09/Scancells-DNA-vaccine-shows-promising-results-in-phase-2-trial-for-skin-cancer.jpg)
Scancellās DNA vaccine shows promising results in phase 2 trial for skin cancer
Anika Sharma
Scancell’s shareholders are enjoying a prosperous week as the biotech company’s stock surged by 20%, driven by promising preliminary data ...